Magnitude of, and Factors Associated with Cardiovascular Disease Among Type Two Diabetes Mellitus Patients

References

• Abraham TM, Pencina KM, Pencina MJ, Fox CS. Trends in diabetes incidence: the Framingham heart study. Diab Care. 2015;38:482–487. doi:10.2337/dc14-1432
   PubMedGoogle Scholar
• International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels: International Diabetes Federation; 2015.
   Google Scholar
• American Diabetes Association. Economic costs of diabetes in the US in2007. Diabetes Care. 2008;31:596–615. doi:10.2337/dc08-9017
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. Diabetes Atlas, International Diabetes Federation Diabetes Atlas. 3rd ed. Brussels, Belgium; 2006.
   Google Scholar
• Bahia LR, Araujo DV, Schaan BD, et al. The costs of type ´ 2 diabetes mellitus outpatient care in the Brazilian public health system. Value Health. 2011;14:137–140.
   PubMed Web of Science ®Google Scholar
• Eddy D, Schlessinger L, Kahn R, Peskin B, Schiebinger R. Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis. Diabetes Care. 2009;32(2):361–366. doi:10.2337/dc08-0854
   PubMed Web of Science ®Google Scholar
• Sarwar N, Gao P, Seshasai SR, et al. Diabetes Mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies emerging risk factors collaboration. Lancet. 2010;375:2215–2222.
   PubMed Web of Science ®Google Scholar
• Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009;53(5):35–42.
   PubMed Web of Science ®Google Scholar
• Singh GM, Danaei G, Farzadfar F, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One. 2013;8.
   Google Scholar
• Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–234. doi:10.1056/NEJM199807233390404
   PubMed Web of Science ®Google Scholar
• Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):83. doi:10.1186/s12933-018-0728-6
   PubMed Web of Science ®Google Scholar
• Fox CS, Pencina MJ, Wilson PW, Paynter NP, Vasan RS, D’Agostino RB. The lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diab Care. 2008;31:1582–1584. doi:10.2337/dc08-0025
   PubMed Web of Science ®Google Scholar
• Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44(1):14–21.
   Google Scholar
• Straka RJ, Liu LZ, Girase PS, DeLorenzo A, Chapman RH. Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting. Cardiovasc Diabetol. 2009;8(1):53. doi:10.1186/1475-2840-8-53
   PubMedGoogle Scholar
• Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. BMC Cardiovasc Diabetol. 2018;17(83):1–19.
   PubMedGoogle Scholar
• World Health Organization. Diet, nutrition and prevention of chronic disease. Report of a joint WHO/FAO expert consultation. Tech Rep. 2003;916.
   Google Scholar
• Mareeswaran N, Savitha AK, Gopalakrishnan S. Prevalence of intestinal parasites among urban and rural population in Kancheepuram district of Tamil Nadu. Int J Community Med Public Health. 2018;5(6). doi:10.18203/2394-6040.ijcmph20182199
   Google Scholar
• Harrison, the principle of internal medicine, 20th ED. 2018;20:3137–3142
   Google Scholar
• Rückert I-M, Maier W, Mielck A, et al. Personal attributes that influence the adequate management of hypertension and dyslipidemia in patients with type 2 diabetes. Results from the DIAB-CORE Cooperation Cardiovascular Diabetology. 2012;11:120.
   PubMedGoogle Scholar
• Bekele S, Yohannes T, Eshete A. Dyslipidemia and associated factors among diabetic patients attending Durame General Hospital in Southern Nations, Nationalities, and People’s Region. Diabetes Metabol Syndr Obesity. 2017;10:265–271. doi:10.2147/DMSO.S135064
   PubMed Web of Science ®Google Scholar
• Nyasatu GC, Elichilia R, Tolbert S, Isaack AL. Lipid profile of Type 2 diabetic patients at a tertiary hospital in Tanzania: cross sectional study. J Endocrinol Diabetes. 2017;4(1):1–6.
   Google Scholar
• Sarfraz M, Sajid S, Ashraf MA. Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population. Saudi J Biol Sci. 2016;23:761–766. doi:10.1016/j.sjbs.2016.03.001
   PubMed Web of Science ®Google Scholar
• Jayarama N, Reddy M, Lakshmaiah V. Prevalence and pattern of dyslipidemia in type 2 diabetes mellitus patients in a rural tertiary care centre, South India. GJMEDPH. 2012;1(3):24.
   Google Scholar
• Noh J, Han KD, Ko SH, Ko KS, Park CY. Trends in the pervasiveness of type 2 diabetes, impaired fasting glucose and co-morbidities during an 8-year-follow-up of nationwide Korean population. Sci Rep. 2017;7(46656):1–7. doi:10.1038/srep46656
   PubMedGoogle Scholar
• Arca M, Pigna G, Favoccia C. Mechanisms of diabetic dyslipidemia: relevance for atherogenesis. Curr Vasc Pharmacol. 2012;10:684–686. doi:10.2174/157016112803520864
   PubMedGoogle Scholar
• Woyesa SB, Hirigo AT, Wube TB. Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia. BMC Endocr Disord. 2018;17:76. doi:10.1186/s12902-017-0226-y
   Google Scholar